Records containing: Pleural Mesothelioma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-01DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
-
CLINICAL_TRIALS study results posted · 2026-07-23A Phase Ib/II Open Label, Multi-arm, Parallel Cohort Dose Finding and Expansion Study to Assess the Safety, Pharmacokinetics and Efficacy of NUC-3373, a Nucleotide Analogue, Given in Combination With Standard Approved Agents in Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1b/2a Multi-Center, Dose Escalation and Reference Regimen-Controlled, Multi-Cohort Study to Determine the Safety and Efficacy of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy in Patients With Locally Advanced or Metastatic Cancers Following One or More Prior Therapies
-
CLINICAL_TRIALS study record update · 2026-04-03A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-30Evaluation of Skin Tests in Biotherapy Allergies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-04From Presentation to Diagnosis: Patterns and Etiologies of Pleural Effusion - A Retrospective Study at Mansoura University
-
CLINICAL_TRIALS study record update · 2026-02-17INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
-
CLINICAL_TRIALS study record update · 2026-01-22DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
-
CLINICAL_TRIALS study record update · 2026-01-13Phase II Study of Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed as Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)
-
CLINICAL_TRIALS study record update · 2025-10-09A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
-
CLINICAL_TRIALS study record update · 2025-10-02A Phase 2 Non-randomized, Open-label, Multi-cohort, Multi-center Study Assessing the Clinical Benefit of SAR444245 (THOR-707) Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2025-08-22TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study - TIGER Meso Study
-
CLINICAL_TRIALS study record update · 2025-07-18A Phase Ib/II Open Label, Multi-arm, Parallel Cohort Dose Finding and Expansion Study to Assess the Safety, Pharmacokinetics and Efficacy of NUC-3373, a Nucleotide Analogue, Given in Combination With Standard Approved Agents in Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2025-07-09A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-03FAPI PET in Pleural Mesothelioma: The Diagnostic Accuracy and Clinical Value of FAPI PET at Diagnosis, Primary Staging, and the Feasibility of FAPI PET for Response Evaluation
-
CLINICAL_TRIALS study record update · 2025-05-13Combining a WT1 Cancer Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Malignant Pleural Mesothelioma: A Phase I Study
-
CLINICAL_TRIALS study record update · 2025-04-02TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
-
CLINICAL_TRIALS study record update · 2024-12-10A Phase 1 Single Arm, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MT027 in Patients with Pleural Malignant Tumors
-
CLINICAL_TRIALS study record update · 2024-07-31A Pilot Window-of-opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2024-05-16Evaluation of the Response to Chemo-Therapy by FLT PET in Mesothelioma
-
CLINICAL_TRIALS study record update · 2024-05-16Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2024-05-08eRAPID: Electronic Monitoring of Patient-reported Symptoms in Patients With a Diagnosis of Thoracic Cancer Managed at Leeds Cancer Centre
-
CLINICAL_TRIALS study record update · 2024-02-21A Phase II, Prospective, Single Arm Trial of Cadonilimab in Combination With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2024-02-01Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2023-06-18Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention